Published papers
Academic conference presentation
    （Last updated : 2026-10-02 14:33:01）
  NAKAYAMA Takayuki
   Department   School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine  Department of Urology
   Position   Assistant Professor
■ Published papers
1. Original article　 Living-donor kidney transplantation after resection of mixed epithelial and stromal tumor: A positive outcome despite not observing the recommended waiting period. 2026/07
2. Original article　 Real‑world outcomes of adjuvant pembrolizumab for renal cell carcinoma: The potential role of PD‑L1 as a prognostic biomarker. 2026/07
3. Original article　 Real-world outcomes of third-line systemic therapy after immune checkpoint inhibitor combinations and subsequent VEGFR-TKIs in advanced renal cell carcinoma. 2026/06/05
4. Case report　 Belzutifan for metastatic TFE3-Rearranged renal cell carcinoma with pulmonary metastases: A Case Report. 2026/05/28
5. Original article　 Non-clear cell renal cell carcinoma has an immune-cold phenotype that affects response to immune checkpoint inhibitors. 2026/05/04
Display all(17)
■ Academic conference presentation
1. Real-world experience with adjuvant pembrolizumab toxicities in renal cell carcinoma: A single-center experience at Tokyo Women's Medical University. （Speech，General） 2026/04/24
2. Experience of adjuvant pembrolizumab in patients with renal cell carcinoma: An initial report using short-term follow-up data. （Poster notice，General） 2026/04/23
3. Mid-term real-world outcome of combination therapy with immune checkpoint inhibitors and VEGFR-TKIs for renal cell carcinoma using minimum 3-year follow-up data. （Speech，General） 2026/04/23
4. Prognostic significance of B Cell and NK cell infiltration in the tumor immune microenvironment of renal cell carcinoma. （Poster notice，General） 2026/04/23
5. Immunotherapy outcomes and immune microenvironment profiles of patients with non-clear cell renal cell carcinoma. （Poster notice，General） 2025/09/26
Display all(7)